To evaluate the clinical importance of TMEM30A, we analysed the expression of TMEM30A in kidney samples from patients with podocytopathy (MCD, MN and DN), samples from patients with IgAN and adjacent normal tissues from patients with renal tumours as controls (clinical information is provided in Table 1). The gene discussed is CDC50A; the disease is liver dysplastic nodule.